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Early Beginnings in China
In October 2003, during the 12th Congress of Oriental Med-
icine in Taipei, the National Palace Museum organized an
enormously pertinent exhibit in Gallery 313 derived largely
from the museum’s collection of ancient medical texts that
includes classics on numerous topics. It is entitled Life is
Worth More than Gold: A Special Exhibition of Ancient
Medicinal Classics. In the English translation of the Chinese
description clues are embedded that pertain to the origins of
both Western medicine and the history of complementary
and alternative medicine (CAM) as briefly described:
“Disease has always been a great topic of concern in human
society. From prayers and spells to the birth of medicine as
a rational science, man has been able to develop all sorts of
medical treatments to combat against different illnesses
and ailments, because, as the Chinese proverb has it, ‘life is
worth more than a thousand gold pieces.’ Towards the end
of the Eastern Han (the 3rd century), typhoid was rampant
in China, and the fatality rate was extremely high. Chang
Chung-ching, with his extensive clinical experience, wrote
the Treatise on Cold-Induced Febrile and Miscellaneous
Diseases, and thereby established the foundations for
‘treatment based on differentiation of symptom-complex’
in traditional Chinese medicine. After that, as governments
began setting up medical institutions and experiences of
private doctors came to be valued, many important medic-
inal theories, treatments and much pharmaceutical knowl-
edge were gradually organized systematically. Advancements
in pharmacology were particularly notable. For example,
the  Newly-Revised Materia Medica issued by Emperor
Kao-tsung of the T’ang dynasty in the 10th year of his reign
(659) was the first pharmacological encyclopedia edited
and published by the government, and a copy was taken to
Japan by Japanese emissaries soon after its completion.”
Why launch Evidence-based Complementary 
and Alternative Medicine (eCAM)?
With this brief excursion into our history, it is appropriate to
mention to those anxious to read our first issue what we are
about. Once again a new journal is born, and in the spring
when there is an awakening from a winter’s sleep, a rejuvena-
tion (reconstruction, renewal, renovation), a renaissance
(rebirth, resurgence, revitalization, revival, reawakening).
Many will greet this birth with mixed feelings. With numer-
ous journals devoted to CAM and already flourishing, other
readers will consider that it is outright nonsense to start yet
another journal devoted to the same subject. Still a greater
number of CAM practitioners and basic scientists of all types
have agreed to serve on the Editorial Board and to support
the aims of eCAM and are certain of the real need for this
journal. We all share various depths of elation and cautious
optimism, partly because we are doing something a bit
unique and partly because of having to compete with other
journals that are devoted exclusively to CAM, or where the
approaches of the authors are such that their manuscripts fit
equally well into more established biomedical journals. In
contrast to these elusive feelings, we also harbor the commit-
ted and strong belief that this new journal, eCAM, will flour-
ish by means of imagination, scientific rigor and cooperative
enthusiasm. All disciplines have beginnings met with enthusi-
asm by founders who must be, of necessity, loyalists—essen-
tial to protect against the onslaught of skepticism that always
seems to occur when a new movement begins. As a develop-
mental immunobiologist, interested in origins and founda-
tions, I am of course steeped in the beginnings of modern
immunology. Let us deal in a bit of musing juxtaposing
immunology, science and CAM.
Can eCAM Be Scientific? Lessons from 
Immunology
According to Burnet (1): 
‘The first objective in a serious approach to immunology
should be to obtain a broad understanding, with a mini-
mum of detail, of how immunology fits into the pattern of
biology—of the way in which the immune system evolved,
its function and coordination with other body systems, and
its development from the embryo onwards. At the same
time, such an outline should provide an adequate back-
ground for easy application of immunological ideas to the2 Editorial
detail of practical immunological work in public health,
clinical, and veterinary practice.’
Would it be possible to paraphrase this statement in the
context of eCAM so that it reads: ‘the first objective in a
serious approach to complementary and alternative medi-
cine (CAM) should be to obtain a broad understanding, with
a minimum of detail, of how CAM fits into the pattern of
biology—of the way in which the neuroendocrineimmune
system evolved, its function and coordination with other body
systems, and its development from the embryo onwards. At
the same time, such an outline should provide an adequate
background for easy application of CAM ideas to the detail
of practical CAM work in public health, clinical and medical
practice, and yet not stray far away from the very biology that
under girds it. CAM is organismic, inclusive and not exclusive
(2–4).
So How do we Define CAM?
So does any of this fit? Readers may be wondering just what
is complementary medicine and what is alternative medicine?
Several definitions may be offered based on different points
of view and those in turn influenced by professional training,
practice and, perhaps, the dictates of funding agencies. The
discipline is a heterogeneous subject, to say the least, and it is
unlikely that all the adherent disciplines that are sheltered by
the umbrella of CAM will carry equal weight or influence or
can be subjected to the same rigors of scientific inquiry. Some
of these generalizations apply to all disciplines, including
those sub-disciplines that fall under the aegis of the immunol-
ogy umbrella. However, perhaps CAM is ripe for an infusion
of empiricism. Modern immunology, like CAM, has its earli-
est roots in concerns for health and disease, but immunology
never seemed to have been branded with the aura that often
shrouds CAM. There were always a group of experimentalists
and, perforce, the necessity to use animal models with which
experimentation could be performed to test hypotheses. (To
be clear and current on all aspects of the discipline, written by
seasoned pioneers, readers are kindly referred to references
5–15 for further reading.)
eCAM is a new concept that encompasses a wider and
more inclusive medical science provided by online systems,
and this more fully integrated concept comprises alternative,
complementary and traditional medicine. At the beginning of
the new century we recognize the tremendous success that
modern medical science has achieved in the diagnosis and
treatment of a number of diseases that were regarded as
incurable for decades. Direct intervention through techno-
logical and molecular means has become possible. We are
now recipients of the full benefit of the progress of modern
medical sciences, and Western medicines in particular. Not-
withstanding, we have also become aware that a comparative
number of diseases still remain incurable by Western medi-
cine, and that patients suffer without any hope of effective
treatment. With all its successes, modern Western medicine
also has limitations such as unbearable side effects, high
medical costs, facilities that are not accessible to everyone,
ethical problems, etc. Recently, alternative and complemen-
tary medicines, together with oriental and traditional
medicines, have attracted much attention. This new interest
includes aromatherapy and herbal medications, acupuncture,
moxibustion, shiatsu and yoga. Often, however, these
therapies have not been well defined. Some are simply based
on legend or belief, while others are traditionally applied but
without scientific evidence.
The Need for eCAM
The recent excessive commercialization of the health indus-
try has left us puzzled as to what is true and what is false.
Misleading information has been flooding into newspapers
and magazines, and exaggerated advertisements can be seen
everywhere (16–20). Yet among these there are credible
accounts. This situation is particularly confusing for patients
and doctors who seek remedies for heretofore undefined
symptoms. Furthermore, since these treatments have not
undergone strict testing, they are not always safe and the
same drug may have different effects according to the indi-
vidual patient and dosage. Complicated considerations are
necessary for the application of practices such as those found
in Chinese traditional medicine. Quality control is also
important for the safe use of natural products. Due to the
above difficulties, this realm of medicine has often been shut
out of the serious journals of Western medicine. Our eCAM
is launched in a desire to ameliorate this situation, by encour-
aging the publication of original scientific papers based on
sound scientific guidelines, but without prejudice against the
possible efficacy of these new and ancient treatments.
A new international journal seeks to understand the
sources and to encourage rigorous research in this new, yet
ancient, world of complementary and alternative medicine.
This international, rigorously peer-reviewed, journal seeks
to apply scientific rigor to the study of CAM modalities,
particularly traditional Asian healing systems. eCAM will
emphasize health outcome, while documenting biological
mechanisms of action and will be devoted to the advance-
ment of science in the fields of basic research, clinical studies,
methodology or scientific theory in diverse areas of biomedi-
cal sciences. With a base in Japan, eCAM will be the first true
platform for scientists and practitioners in Asia. With Asia
as their home, these contributors are familiar with the way
many CAM techniques have been practiced for centuries,
giving the journal a firm footing in the history and tradition
of CAM. As with any truly important research, one must
think radically; in other words, return to the radical or root of
a question or practice. A greater understanding of thousands
of years of history will give us greater access to the root and
may well lead to exciting new discoveries. CAM is a world-
wide phenomenon and eCAM will seek to be inclusive of new
and old work all over the globe. With this same broad view,
we will seek to make the journal truly inter-disciplinary with a
varied editorial board on which philosophers and historianseCAM 2004;1(1) 3
will be engaged in dialogue with biologists of all types and
clinicians. It is our hope that the two bases, one in the east
and the other in the West, especially at UCLA, will be gather-
ing places for information and that our combined efforts will
bridge cultures as well as CAM and modern biomedicine.
The Future and Impact of eCAM
So where are we? We began in China in a historical context,
laying a foundation for CAM and Western medicine with the
inference that bridges could be built. By linking the scientific
basis of CAM with another discipline that too was once fledg-
ling, now free from lack of empiricism, a foundation of hope
was laid and the suggestion of animal models and natural
products inferred. According to Normile (10), there is a new
face to traditional Chinese medicine. Asian governments
hope that high-volume screening and rigorous clinical trials
will unlock the secrets of ancient herbal remedies—and that
the results will pass muster with Western scientists. According
to Vickers (21), there appears to be exceptional and growing
public enthusiasm for botanical, or ‘herbal’, medicines, espe-
cially amongst cancer patients. This has recently begun to be
matched by increasing scientific attention. Quality control of
botanicals poses significant challenges: small differences in
genetics, soil, temperature, moisture and time of harvesting
can lead to significant differences in the concentration of
important constituents. Phase I and II methodology is also
problematic: botanicals have low toxicity and are unlikely to
cause rapid tumor regression. There is currently minimal
regulation of botanical medicines.
Turning to products from animals, particularly those from
the sea, according to Haefner (22), in recent years marine
natural product bioprospecting has yielded a considerable
number of drug candidates. Most of these molecules are still
in preclinical or early clinical development but some are
already on the market, such as cytarabine, or are predicted to
be approved soon, such as ET743 (Yondelis). Research into
the ecology of marine natural products has shown that many
of these compounds function as chemical weapons and have
evolved into highly potent inhibitors of physiological proc-
esses in the prey, predators or competitors of the marine
organisms that use them. Some of the natural products iso-
lated from marine invertebrates have been shown, or are sus-
pected, to be of microbial origin and this is now thought to be
the case for the majority of such molecules. Marine micro-
organisms, whose immense genetic and biochemical diversity
is only beginning to be appreciated, look likely to become a
rich source of novel chemical entities for the discovery of
more effective drugs. Lombrokinase is a product isolated from
earthworms and sold on the market as a fibrinolytic agent
(23). We must remember that these products are often associ-
ated with the immune systems of these creatures and that
they evolved millions of years ago—thus their immune sys-
tems have been an effective survival strategy (24–30). And if
it has worked for them, then humans should harness these as
new-wave antibiotics or anticancer molecules, just to offer
two biomedical (CAM) applications.
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